58B-18998-78407 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-30
Dose 1 — Pfizer-BioNTech
2021-04-22
Dose 2 — Pfizer-BioNTech
2021-04-24
Registered in v-safe
2021-04-24
Survey response — days 1–6 daily, dose 2
MedDRA: Abortion spontaneous — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Free text: Miscarriage

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-25
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-26
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-07-22
Survey response — 3 months, dose 2
MedDRA: Dermatitis atopic — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Atopic dermatitis

MedDRA releases: 2024-11 · check-in free text available
2021-07-22
Report sent to call center — 3 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-07-26
Call successful
Participant prefers to complete VAERS report online
2022-04-24
Health check-in — 12 months, dose 2
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-30	Pfizer-BioNTech
2	2021-04-22	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-07-22	Successful 2021-07-26	Participant prefers to complete VAERS report online

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-24

Systemic reaction (other): Miscarriage

Release 9 — 3 months, dose 2

2021-07-22

Symptoms: Atopic dermatitis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dermatitis atopic	·	·	✓
SRO	Abortion spontaneous	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release